FDA Inspection 1317698 — Charles E. Bugg, Jr., M.D.
The FDA completed an inspection of Charles E. Bugg, Jr., M.D. on April 16, 2026 in Homewood, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 16, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Homewood, AL (United States)
Additional Details
Clinical Investigator (CI)